Page last updated: 2024-08-23

bm 13505 and mocetinostat

bm 13505 has been researched along with mocetinostat in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lefer, AM; Ma, XL; Viehman, GE	1
DiMartino, MJ; Egan, JW; Griswold, DE; Hillegass, LM; Smith, EF	1

Other Studies

2 other study(ies) available for bm 13505 and mocetinostat

Article	Year
Daltroban, a thromboxane receptor antagonist, protects the myocardium against reperfusion injury following myocardial ischemia without protecting the coronary endothelium. Methods and findings in experimental and clinical pharmacology, 1990, Volume: 12, Issue:10 Topics: Animals; Cats; Coronary Vessels; Endothelium, Vascular; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Peroxidase; Phenylacetates; Sulfonamides; Thromboxanes; Vasoconstriction	1990
Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505. Journal of cardiovascular pharmacology, 1989, Volume: 13, Issue:5 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiomyopathies; Creatine Kinase; Hemodynamics; Male; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Peroxidase; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxanes	1989

Article

Year

Daltroban, a thromboxane receptor antagonist, protects the myocardium against reperfusion injury following myocardial ischemia without protecting the coronary endothelium.

Methods and findings in experimental and clinical pharmacology, 1990, Volume: 12, Issue:10

Topics: Animals; Cats; Coronary Vessels; Endothelium, Vascular; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Peroxidase; Phenylacetates; Sulfonamides; Thromboxanes; Vasoconstriction

1990

Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.

Journal of cardiovascular pharmacology, 1989, Volume: 13, Issue:5

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiomyopathies; Creatine Kinase; Hemodynamics; Male; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Peroxidase; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxanes

1989